A detailed history of Transamerica Financial Advisors, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Transamerica Financial Advisors, Inc. holds 61,546 shares of BSX stock, worth $5.6 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
61,546
Previous 63,750 3.46%
Holding current value
$5.6 Million
Previous $4.91 Million 5.05%
% of portfolio
0.5%
Previous 0.52%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$72.96 - $84.0 $160,803 - $185,136
-2,204 Reduced 3.46%
61,546 $5.16 Million
Q1 2024

May 15, 2024

BUY
$57.6 - $68.62 $3.34 Million - $3.98 Million
58,041 Added 1016.66%
63,750 $4.37 Million
Q4 2023

Feb 12, 2024

BUY
$48.64 - $57.81 $248,842 - $295,755
5,116 Added 862.73%
5,709 $331,000
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $29,762 - $32,425
593 New
593 $32,000
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $474 - $566
12 New
12 $1,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Transamerica Financial Advisors, Inc. Portfolio

Follow Transamerica Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transamerica Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Transamerica Financial Advisors, Inc. with notifications on news.